IDH3A and glioblastoma: Mutation in isocitrate dehydrogenase (IDH) enzyme is an essential pathological hallmark in the pathogenesis of GBM, and based on the mutation status of both IDH 1 and 2, GBM is subdivided into three different groups including IDH wild type, IDH mutant, and not specified [3–5].